Home
Platform
Services
Brands
Locations
Careers
News
Library
Responsibility
Contact Us
Platform
Our Platform
Our Competitive Edge
Services
Preclinical Development
Clinical Development
Regulatory Affairs & Consulting
Data Sciences
Molecular Laboratory R&D Services
Microbiology and Diagnostics R&D Services
Brands
Clinglobal
About us
Our Services
Our Team
Clinvet
About us
Our Services
Our Team
Clindata
About us
Our Services
Our Team
Clinomics
About us
Our Services
Our Team
Clinaxel
Rtilab
Locations
Careers
News
Social Media
Library
Research Models
Publications
Responsibility
Our Purpose
Our Values
Corporate Responsibility
Compliance
Contact us
Evaluation of the efficacy of monthly oral administration of afoxolaner plus milbemycin oxime (NexGard Spectra((R)), Merial) in the prevention of adult Spirocerca lupi establishment in experimentally infected dogs
Home
Evaluation of the efficacy of monthly oral administration of afoxolaner plus milbemycin oxime (NexGard Spectra((R)), Merial) in the prevention of adult Spirocerca lupi establishment in experimentally infected dogs
digitalplatforms
April 24, 2025
0 Comments
File Type:
pdf
File Size:
2 MB
Categories:
Publications
Post navigation
Previous
Evaluation of the efficacy of emodepside+praziquantel topical solution against cestode (Dipylidium caninum, Taenia taeniaeformis, and Echinococcus multilocularis) infections in cats
Next
Evalutaion of fetal protection against experimental infection with type 1 and type 2 BVDv after vaccination with a bivalent modified-live virus vaccine _ J. Am. Vet. Med. Assoc
